Lupus patients unable to get medicine
Although belimumab, known by the brand name Benlysta, was registered in 2011 in the USA, the South African Health Products Regulatory Authority (SAHPRA) has still not given approval for its use in South Africa.
This is according to Susan van der Walt from the Lupus Foundation of South Africa, who has been fighting for seven years to get Benlysta registered.
Lupus is a chronic and complex autoimmune disease where a sufferer’s immune system attacks healthy cells by mistake. It can affect a person’s joints, skin, brain, lungs, kidneys, and blood vessels, causing widespread inflammation and tissue damage.
South Africa treats lupus with steroids, chemotherapy and anti-rejection medication, suppressing the entire immune system, whereas Benlysta targets specific immune cells.
Correct medication
Van der Walt says that, while lupus cases seem to be increasing, there is little awareness about it.
“As a private organisation, we do as much as possible to create awareness but our government needs to get involved and realise that lupus is a huge problem that needs to be addressed. The correct medication should also be registered and made available in the country,” she said.
Women between the ages of 15 and 44 are most likely to suffer from the disease but it can affect anyone.
Rashni Nirvana Harichand (41) had pain on her left hand from the wrist to her fingers. She initially thought she had hurt herself and took pain killers.
“This went on for a few weeks until I could not hold anything with my left hand. The pain travelled all the way from my left breast down to my fingers. The pain felt like pins and needles and was very sensitive.”
Tests
She decided to seek medical help and after blood tests was told that she had “Mixed Connective Tissue”.
“I was terrified and did not know what to do. I went for a second opinion and was told that I had Carpal Tunnel Syndrome (CTS) and that I would be fine after an operation.”
But after less than a week on medication for CTS, her body swelled and everything hurt.
“I went for a third opinion and was told I had lupus. Two years later and I am still trying to understand lupus but I am dealing with it on my own terms,” she said.
Attempts to get a comment from the health department were unsuccessful. – Health-e News
An edited version of this story was published by Health24.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Lupus patients unable to get medicine
by Marcia Moyana, Health-e News
April 2, 2019